Related Experiment Videos
Suppressor versus cytolytic CD8+ T lymphocytes: where are the artefacts?
Scandinavian Journal of Immunology
|June 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The genetic landscape of mitochondrial diseases in the next-generation sequencing era: a Portuguese cohort study.
Frontiers in cell and developmental biology·2024
Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
European journal of clinical nutrition·2017
Nuclear Factor Kappa B (NF-κB)1 and NF-κB2 Deficiency: An Unpredictable Defect With Wide Clinical and Immunologic Phenotype.
Scandinavian journal of immunology·2026
Evolution and Mechanistic Insights of Immunometabolism in Metabolic Diseases and Infections.
Scandinavian journal of immunology·2026
From Validation to Clinical Interpretation: A Flow Cytometric Th17-Cell Assay for STAT1- and STAT3-Related Inborn Errors of Immunity.
Scandinavian journal of immunology·2026
Impact of CD38 Deficiency on B Cell Development in CD19-Deficient Mice.
Scandinavian journal of immunology·2026
Decreased PD-1+ NK and T Cell Populations in Peritoneal Fluid contribute to Immune Dysregulation in Endometriosis.
Scandinavian journal of immunology·2026
Impact of Bacterial Membrane Vesicles on Cellular Responses in Leishmania amazonensis-Infected Macrophages In Vitro.
Scandinavian journal of immunology·2026
Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.
The Journal of dermatology·2026
Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.
Apoptosis : an international journal on programmed cell death·2026
Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.
Frontiers in oncology·2026
Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.
Nature reviews. Cancer·2026
Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.
Clinical rheumatology·2026